These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 30063918)

  • 1. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
    Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer and advanced adenoma characteristics according to causative mismatch repair gene variant in Japanese colorectal surveillance for Lynch syndrome.
    Chino A; Tanakaya K; Nakajima T; Akagi K; Takao A; Yamada M; Ishida H; Komori K; Sasaki K; Miguchi M; Hirata K; Sudo T; Miyakura Y; Ishikawa T; Yamaguchi T; Tomita N; Ajioka Y
    J Gastroenterol; 2024 Aug; 59(8):699-708. PubMed ID: 38902413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome.
    Sánchez A; Roos VH; Navarro M; Pineda M; Caballol B; Moreno L; Carballal S; Rodríguez-Alonso L; Ramon Y Cajal T; Llort G; Piñol V; López-Fernández A; Salces I; Picó MD; Rivas L; Bujanda L; Garzon M; Pizarro A; Martinez de Castro E; López-Arias MJ; Poves C; Garau C; Rodriguez-Alcalde D; Herraiz M; Alvarez-Urrutia C; Dacal A; Carrillo-Palau M; Cid L; Ponce M; Barreiro-Alonso E; Saperas E; Aguirre E; Romero C; Bastiaansen B; Gonzalez-Acosta M; Morales-Romero B; Ocaña T; Rivero-Sánchez L; Jung G; Bessa X; Cubiella J; Jover R; Rodríguez-Moranta F; Balmaña J; Brunet J; Castells A; Dekker E; Capella G; Serra-Burriel M; Moreira L; Pellise M; Balaguer F
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):611-621.e9. PubMed ID: 33157315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
    Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy.
    Lappalainen J; Holmström D; Lepistö A; Saarnio J; Mecklin JP; Seppälä T
    Scand J Gastroenterol; 2019 Dec; 54(12):1473-1480. PubMed ID: 31829749
    [No Abstract]   [Full Text] [Related]  

  • 7. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X.
    Bucksch K; Zachariae S; Ahadova A; Aretz S; Büttner R; Görgens H; Holinski-Feder E; Hüneburg R; Kloor M; von Knebel Doeberitz M; Ladigan-Badura S; Moeslein G; Morak M; Nattermann J; Nguyen HP; Perne C; Redler S; Schmetz A; Steinke-Lange V; Surowy H; Vangala DB; Weitz J; Loeffler M; Engel C;
    Int J Cancer; 2022 Jan; 150(1):56-66. PubMed ID: 34469588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes.
    Goverde A; Eikenboom EL; Viskil EL; Bruno MJ; Doukas M; Dinjens WNM; Dubbink EJ; van den Ouweland AMW; Hofstra RMW; Wagner A; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1112-1120.e1. PubMed ID: 31470178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.
    Vale Rodrigues R; Claro I; Lage P; Rosa I; Ferreira S; Pereira da Silva J; Dias Pereira A
    Int J Colorectal Dis; 2018 Jun; 33(6):695-702. PubMed ID: 29523990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer.
    Lamba M; Wakeman C; Ebel R; Hamilton S; Frampton C; Kiesanowski M; Griffiths B; Keating J; Parry S; Chalmers-Watson T
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2768-2774. PubMed ID: 32240831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequacy evaluation of the annual colonoscopic surveillance and individual difference of disease phenotypes in Lynch syndrome.
    Taniguchi F; Tanakaya K; Sugano K; Akagi K; Ishida H; Nagahisa S; Nishimura S; Une Y; Kimura Y; Watanabe M; Utsumi M; Aoki H
    Jpn J Clin Oncol; 2020 Jun; 50(6):635-642. PubMed ID: 32372090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.
    Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
    Seppälä TT; Ahadova A; Dominguez-Valentin M; Macrae F; Evans DG; Therkildsen C; Sampson J; Scott R; Burn J; Möslein G; Bernstein I; Holinski-Feder E; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Lautrup CK; Lindblom A; Plazzer JP; Winship I; Tjandra D; Katz LH; Aretz S; Hüneburg R; Holzapfel S; Heinimann K; Valle AD; Neffa F; Gluck N; de Vos Tot Nederveen Cappel WH; Vasen H; Morak M; Steinke-Lange V; Engel C; Rahner N; Schmiegel W; Vangala D; Thomas H; Green K; Lalloo F; Crosbie EJ; Hill J; Capella G; Pineda M; Navarro M; Blanco I; Ten Broeke S; Nielsen M; Ljungmann K; Nakken S; Lindor N; Frayling I; Hovig E; Sunde L; Kloor M; Mecklin JP; Kalager M; Møller P
    Hered Cancer Clin Pract; 2019; 17():8. PubMed ID: 30858900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry.
    Aronson M; Gryfe R; Choi YH; Semotiuk K; Holter S; Ward T; Gallinger S; Cohen Z; Briollais L
    J Natl Cancer Inst; 2023 Jul; 115(7):778-787. PubMed ID: 36964717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
    Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
    Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
    Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
    J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the appropriate screening protocol in Lynch syndrome?
    de Jong AE; Nagengast FM; Kleibeuker JH; van de Meeberg PC; van Wijk HJ; Cats A; Griffioen G; Vasen HF
    Fam Cancer; 2006; 5(4):373-8. PubMed ID: 16826316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?
    Anyla M; Lefevre JH; Creavin B; Colas C; Svrcek M; Lascols O; Debove C; Chafai N; Tiret E; Parc Y
    Int J Colorectal Dis; 2018 Jun; 33(6):703-708. PubMed ID: 29532206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.